Circulating nucleic acids as possible damage-associated molecular patterns in different stages of renal failure

REFERENCES

• Parmar MS. Chronic renal disease. BMJ. 2002;325(7355):85–90.
   PubMedGoogle Scholar
• Rangan G, Wang Y, Harris D. NF-kappaB signalling in chronic kidney disease. Front Biosci. 2009;14:3496–3522.
   Google Scholar
• Ma FY, Liu J, Nikolic-Paterson DJ. The role of stress-activated protein kinase signaling in renal pathophysiology. Braz J Med Biol Res. 2009;42(1):29–37.
   PubMed Web of Science ®Google Scholar
• Lotze MT, Zeh HJ, Rubartelli A, The grateful dead: Damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev. 2007;220(1): 60–81.
   PubMedGoogle Scholar
• Rubartelli A, Lotze MT. Inside, outside, upside down: Damage-associated molecular pattern molecules (DAMPs) and redox. Trends Immunol. 2007;28(10):429–436.
   PubMed Web of Science ®Google Scholar
• Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994;12:991–1045.
   PubMed Web of Science ®Google Scholar
• Foell D, Wittkowski H, Roth J. Mechanisms of disease: A “DAMP” view of inflammatory arthritis. Nat Clin Pract Rheumatol. 2007;3(7):382–390.
   PubMedGoogle Scholar
• Barrat FJ, Meeker T, Gregorio J, Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Environ Monit. 2005;202(8):1131–1139.
   Google Scholar
• Navab M, Gharavi N, Watson AD. Inflammation and metabolic disorders. Curr Opin Clin Nutr Metab Care. 2008; 11(4):459–464.
   PubMedGoogle Scholar
• Pawar RD, Patole PS, Wörnle M, Anders HJ. Microbial nucleic acids pay a Toll in kidney disease. Am J Physiol Renal Physiol. 2006;291:F509–F516.
   Google Scholar
• Mollen KP, Rahul JP, Tsung A, Prince JM, Levy RM, Billiar TR. Emerging paradigm: Toll like receptor 4- sentinel for the detection of tissue damage. Shock. 2006;26(5):430–437.
   PubMedGoogle Scholar
• Diebold SS, Kaisho T, Hemmi H, Akira S, Sousa R. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004;303:1529–1531.
   PubMed Web of Science ®Google Scholar
• Deane AJ, Bolland S. Nucleic acid-sensing TLRs as modifiers of autoimmunity. J Immunol. 2006;177:6573–6578.
   Google Scholar
• Moriyama H, Wen L, Abiru N, Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidilyc acid) and an insulin self-peptide. Proc Natl Acad Sci U S A. 2002;99:5539–5544.
   PubMed Web of Science ®Google Scholar
• Schein CH. From housekeeper to microsurgeon: The diagnostic and therapeutic potential of ribonucleases. Nature Biotechnol. 1997;15:529–536.
   PubMed Web of Science ®Google Scholar
• Kocic G, Bjelakovic G, Saranac LJ, Altered degradation of circulating nucleic acids and oligonucleotides in diabetic patients. Diabetes Res Clin Pract. 2008;79(2):204–213.
   PubMedGoogle Scholar
• Kocic G, Kocic R, Pavlovic R, Possible impact of impaired double-stranded RNA degradation and nitrosative stress on immunoinflammatory cascade in type 2 diabetes. Exp Clin Endocrinol Diabetes. 2009;117:1–6.
   PubMedGoogle Scholar
• National Kidney Foundation – K/DOQI. Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis. 2002;39(Suppl. 1):S1–S266.
   PubMedGoogle Scholar
• Cavaluzzi M, Borer P. Revised UV extinction coefficients for nucleoside-5′-monophosphates and unpaired DNA and RNA. Nucleic Acids Res. 2004;32:e1–e13.
   PubMedGoogle Scholar
• Reimer T, Brcic M, Schweizer M, Jungi TW. Poly(I:C) and LPS induce distinct IRF3 and NF-κB signaling during type-I IFN and TNF responses in human macrophages. J Leukoc Biol. 2008;83:1249–1257.
   PubMed Web of Science ®Google Scholar
• Gelman AE, Zhang J, Chol Y, Turka LA. Toll-like receptor ligands directly promote activated CD4+T cell survival. J Immunol. 2004;172:6065–6073.
   PubMed Web of Science ®Google Scholar
• Wardle EN. Toll-like receptors and glomerulonephritis. Saudi J Kidney Dis Transpl. 2007;18:159–172.
   PubMedGoogle Scholar
• Pascual V, Farkas L, Banchereau J. Systemic lupus erythematosus: All roads lead to type 1 interferons. Curr Opin Immunol. 2006;18:676–682.
   PubMed Web of Science ®Google Scholar
• Lang KS, Recher M, Junt T, Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med. 2005;11:138–145.
   PubMed Web of Science ®Google Scholar
• Konda R, Sugimura J, Sohma F, Katagiri T, Nakamura Y, Fujioka T. Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappa B is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure. J Urol. 2008;180(2):481–485.
   PubMedGoogle Scholar
• Seimon TA, Wang Y, Han S, Macrophage deficiency of p38α MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. J Clin Invest. 2009;119(4):886–898.
   PubMed Web of Science ®Google Scholar
• Maung AA, Fujimi S, Miller ML, MacConmara MP, Mannick JA, Lederer JA. Enhanced TLR4 reactivity following injury is mediated by increased p38 activation. J Leukoc Biol. 2005;78:565–573.
   PubMedGoogle Scholar
• Toshiro K, Hiroki Y, Hiroaki S, Kentaro K, Toshiko T, Noriyuki T. Role of p38 mitogen-activated protein kinase pathway on renal failure in the infant rat after burn injury. Shock. 2004;21(6):535–542.
   PubMedGoogle Scholar
• Tsoulfas G, Geller DA. NF-κB in transplantation: Friend or foe? Transpl Infect Dis. 2001;3(4):212–219.
   PubMedGoogle Scholar
• Kato H, Takeuchi O, Sato S, Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441:101–105.
   PubMed Web of Science ®Google Scholar
• Yeow WS, Au WC, Lowther WJ, Pitha PM. Downregulation of IRF-3 levels by ribozyme modulates the profile of IFNA subtypes expressed in infected human cells. J Virol. 2001; 75(6):3021–3027.
   PubMedGoogle Scholar
• Peters K, Chattopadhyay S, Sen GC. IRF-3 activation by sendai virus infection is required for cellular apoptosis and avoidance of persistence. J Virol. 2008;82(7):3500–3508.
   PubMedGoogle Scholar
• Hiscott J. Triggering the innate antiviral response through IRF-3 activation. J Biol Chem. 2007;282(21):15325–15329.
   PubMedGoogle Scholar
• Claesson K, Rönnblom L, Alm G, Tufveson G. Antiviral activity appearing in serum of renal transplant recipients. Its possible relation to immunological rejection. Transplantation. 1984; 38(1):32–34.
   PubMedGoogle Scholar
• Rostaing L, Modesto A, Baron E, Cisterne JM, Chabannier MH, Durand D. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. Nephron. 1996;74(3):512–516.
   PubMedGoogle Scholar